- June 6, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Nuzyra
Synonyms :
omadacycline
Class :
Tetracyclines
Dosage Forms & Strengths
Tablet
150mg
Loading Dose: 200 mg via IV infusion for 1 hour on day 1 or 100 mg via IV infusion for 30mins two times on day 1 or 300 mg orally two times on day 1
Maintenance Dose: 100 mg via IV infusion for 30mins per day or 300 mg orally per day
the maximum duration of treatment is 7-14 days
Loading Dose: 200 mg via IV infusion for 1 hour on day 1 or 100 mg via IV infusion for 30mins two times on day 1 or 300 mg orally two times on day 1
Maintenance Dose: 100 mg via IV infusion for 30mins per day or 300 mg orally per day
the maximum duration of treatment is 7-14 days
when both drugs are combined, there may be increased toxicity of omadacycline
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with iron preparations
may diminish the absorption when combined with iron preparations
may diminish the absorption when combined with iron preparations
may diminish the absorption when combined with iron preparations
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
may diminish the absorption of iron preparations
may diminish the serum concentration when combined with tetracyclines
may diminish the serum concentration when combined with tetracyclines
may diminish the absorption of magnesium salts
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
aluminum hydroxide/magnesium carbonate
may decrease the serum concentration of antacids
when both drugs are combined, there may be a decreased effects of amoxicillin
when both drugs are combined, there may be a decreased effects of ampicillin
when both drugs are combined, there may be an increased effect of atracurium
when both drugs are combined, there may be increased toxicity of omadacycline
when both drugs are combined, there may be a decreased effect of the vaccine
when both drugs are combined, there may be an increased effect of cisatracurium
when both drugs are combined, there may be an increased effect of dicloxacillin
when both drugs are combined, there may be increased toxicity of omadacycline
when both drugs are combined, there may be a decreased effect of nafcillin
when both drugs are combined, there may be a decreased effect of oxacillin
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with omadacycline it decreases the effects of action of drug by antagonism effect
amoxicillin and clavulanate potassium
when amoxicillin combines with omadacycline it decreases the effects of action of drug by antagonism effect
omeprazole amoxicillin and clarithromycin
when both drugs are combined, there may be a decreased effect of the drug's action by antagonism effect
when both drugs are combined, there may be a decreased effect of the drug's action by antagonism effect
may diminish the absorption of magnesium salts
aluminum hydroxide/magnesium hydroxide
may diminish the absorption of Antacids
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
when both drugs are combined, there may be a decreased effect of omadacycline by inhibition of gi absorption
tetracyclines may diminish the therapeutic effect of penicillins
tetracyclines may diminish the therapeutic effect of penicillins
tetracyclines may diminish the therapeutic effect of penicillins
tetracyclines may diminish the therapeutic effect of penicillins
tetracyclines may diminish the therapeutic effect of penicillins
may enhance the risk of adverse effect of retinoic acid derivatives
may enhance the risk of adverse effect of retinoic acid derivatives
may enhance the risk of adverse effect of retinoic acid derivatives
may enhance the risk of adverse effect of retinoic acid derivatives
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
may reduce the therapeutic effect of penicillins
amoxicillin and clavulanate potassium
may reduce the therapeutic effect of penicillins
may reduce the therapeutic effect of penicillins
may reduce the therapeutic effect of penicillins
may reduce the therapeutic effect of penicillins
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may enhance the neuromuscular-blocking effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
It may diminish the levels when combined with sodium acid phosphate by inhibiting of gastrointestinal absorption
They may diminish the absorption when combined with bile acid sequestrants
The inhibition of gastrointestinal absorption caused by potassium aminobenzoate will result in a reduction in the level of omadacycline
It may diminish the effect when combined with manganese by inhibiting the gastrointestinal absorption
it may diminish the excretion rate when combined with tetracyclines, resulting in an enhanced serum level
may decrease the therapeutic effect when combined with penicillins
may decrease the therapeutic effect when combined with penicillins
The interaction may depress the therapeutic efficacy of tetracyclines
The interaction may depress the therapeutic efficacy of tetracyclines
The interaction may depress the therapeutic efficacy of tetracyclines
The interaction may depress the therapeutic efficacy of tetracyclines
The interaction may depress the therapeutic efficacy of tetracyclines
The interaction may depress the therapeutic efficacy of tetracyclines
may increase the hypoglycemic effect of sulfonylureas
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the rate of absorption
may decrease the rate of absorption
may decrease the rate of absorption
may decrease the rate of absorption
may diminish the absorption of magnesium salts
may diminish the absorption when combined with tetracyclines
Adverse drug reactions:
Frequency defined
>10%
